Aurora Cannabis (ACB) Scheduled to Post Quarterly Earnings on Monday

Aurora Cannabis (NYSE:ACB) is set to issue its quarterly earnings data on Monday, September 18th.

Aurora Cannabis (NYSE:ACB) last issued its earnings results on Thursday, August 10th. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. The firm had revenue of $55.92 million for the quarter, compared to analyst estimates of $46.80 million. Aurora Cannabis had a negative return on equity of 30.47% and a negative net margin of 88.27%. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Aurora Cannabis Price Performance

Shares of NYSE ACB opened at $0.98 on Friday. The business’s 50 day moving average price is $0.55 and its 200 day moving average price is $0.60. The firm has a market cap of $390.11 million, a P/E ratio of -1.89 and a beta of 2.58. Aurora Cannabis has a 52 week low of $0.43 and a 52 week high of $1.62. The company has a quick ratio of 3.16, a current ratio of 4.08 and a debt-to-equity ratio of 0.33.

Hedge Funds Weigh In On Aurora Cannabis

A number of institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its holdings in Aurora Cannabis by 72.8% during the second quarter. Goldman Sachs Group Inc. now owns 1,269,306 shares of the company’s stock worth $679,000 after buying an additional 534,615 shares in the last quarter. Ergoteles LLC boosted its holdings in Aurora Cannabis by 1,012.9% during the second quarter. Ergoteles LLC now owns 147,482 shares of the company’s stock worth $79,000 after buying an additional 134,230 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Aurora Cannabis by 37.8% during the second quarter. JPMorgan Chase & Co. now owns 341,751 shares of the company’s stock worth $2,970,000 after buying an additional 93,747 shares in the last quarter. Gallagher Fiduciary Advisors LLC purchased a new stake in Aurora Cannabis during the first quarter worth $34,000. Finally, Bank of America Corp DE boosted its holdings in Aurora Cannabis by 38.5% during the first quarter. Bank of America Corp DE now owns 321,326 shares of the company’s stock worth $224,000 after buying an additional 89,300 shares in the last quarter. Hedge funds and other institutional investors own 11.17% of the company’s stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.